Platelet transfusions are not associated with increased morbidity or mortality in cardiac surgery

Canadian Journal of Anesthesia

Volumn 53, Issue 3, 2006, Pages 279-287

  Karkouti, Keyvan ^a   Wijeysundera, Duminda N ^a   Yau, Terrence M ^a   Callum, Jeannie L ^a   Meineri, Massimiliano ^a   Wasowicz, Marcin ^a   McCluskey, Stuart A ^a   Beattie, W Scott ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEATH; FEMALE; FORWARD HEART FAILURE; HEART INFARCTION; HEART SURGERY; HUMAN; INFORMATION PROCESSING; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SEPSIS; STROKE; SURGICAL PATIENT; THROMBOCYTE TRANSFUSION;

CARDIAC SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET TRANSFUSION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 33645932009     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03022216     Document Type: Article

References (24)

1. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001; 97: 1180-95.
2. Raghavan M, Marik PE. Anemia, allogenic blood transfusion, and immunomodulation in critically ill. Chest 2005; 127: 295-307.
3. Vamvakas EC, Carven JH. Allogeneic blood transfusion and postoperative duration of mechanical ventilation: effects of red cell supernatant, platelet supernatant, plasma components and total transfused fluid. Vox Sang 2002; 82: 141-9.
4. Spiess BD, Royston D, Levy JH, et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse events. Transfusion 2004; 44: 1143-8.
5. Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004; 44: 1453-62.
6. Katz MH. Multivariable Analysis: a Practical Guide for Clinicians, 1st ed. Cambridge: Cambridge University Press; 1999.
7. Feinstein AR. Multiple logistic regression. In: Feinstein AR (Ed.). Multivariable Analysis: an Introduction. New Haven: Yale University Press; 1996: 297-330.
8. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-81.
9. Parson LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-sixth Annual SAS® Users Group International Conference, Long Beach, CA, 2001.
10. Schlesselman JJ. Case-control studies: design, conduct, analysis. New York: Oxford University Press; 1982.
11. Allison PD. Logit analysis of longitudinal and other clustered data. In: Allison PD (Ed.). Logistic Regression Using SAS System: Theory and Application. Cary, NC: SAS Institute and Wiley; 1991: 179-216.
12. Boehlen F, Clemetson KJ. Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? Transf Med 2001; 11: 403-17.
13. Spiess BD. Risks of transfusion: outcome focus. Transfusion 2004; 44: 4S-14S.
14. Corwin HL, AuBuchon JP. Is leukoreduction of blood components for everyone? JAMA 2003; 289: 1993-5.
15. Heddle NM. Universal leukoreduction and acute transfusion reactions: putting the puzzle together (Editorial). Transfusion 2004; 44: 1-4.
16. Stephan F, Hollande J, Richard O, Cheffi A, Maier-Redelsperger M, Flahautl A. Thrombocytopenia in a surgical intensive care unit: incidence, risk factors and outcome. Chest 1999; 115: 1363-70.
17. Itescu S, Tung TC, Burke EM, et al. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation 1998; 98: 786-93.
18. Kristiansson M, Soop M, Saraste L, Sundqvist KGl. Cytokines in stored red blood cell concentrates: promoters of systemic inflammation and simulators of acute transfusion reactions? Acta Anaesthesiol Scand 1996; 40: 496-501.
19. 2. Shock 2000; 13: 29-33.
20. Buttnerova I, Baumler H, Kern F, et al. Release of WBC-derived IL-1 receptor antagonist into supernatants of RBCs: influence of storage time and filtration. Transfusion 2001; 41: 67-73.
21. Lin JS, Tzeng CH, Hao TC, et al. Cytokine release in febrile non-haemolytic red cell transfusion reactions. Vox Sang 2002; 82: 156-60.
22. Spiess BD. Transfusion of blood products affects outcome in cardiac surgery. Semin Cardiothoracic Vasc Anest 2004; 8: 267-81.
23. Spahn DR. Strategies for transfusion therapy. Best Pract Res Clin Anaesthesiol 2004; 18: 661-73.
24. Smith RC, Leung JM, Mangano DT. Postoperative myocardial ischemia in patients undergoing coronary artery bypass graft surgery. S.P.I. Research Group. Anesthesiology 1991; 74: 464-73.